Skip to main content

Month: February 2021

Saniona postpones 2020 year-end financial report due to restatement and re-audit of prior period financial statements in line with U.S. PCAOB audit standards

PRESS RELEASEFebruary 22, 2021Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, as part of its previously announced evaluation of a potential listing of its shares on the U.S. Nasdaq exchange, Saniona is conducting a company-initiated restatement of prior period financial statements and a subsequent audit of these financial statements under U.S. Public Company Accounting Oversight Board (PCAOB) audit standards. This will result in the postponement of its 2020 year-end report. The 2020 year-end report will be issued on 17 March 2021.Saniona deems the restatements, which relate to accounting adjustments, to not be material from a business perspective because they will not impact the Company’s cash position, forecast, operating plan or the conduct of its clinical trials.In preparation...

Continue reading

Saniona senarelägger publicering av bokslutskommuniké för 2020 till följd av omräkning och förnyad revision av tidigare finansiella rapporter för att uppfylla amerikanska revisionsstandarder

PRESSMEDDELANDE22 februari 2021Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att bolaget, som ett led i den tidigare aviserade utvärderingen av en möjlig notering av aktien på den amerikanska Nasdaq-börsen, genomför en företagsinitierad omräkning av tidigare finansiella rapporter och en revision av dessa i enlighet med revisionsstandarden från Public Company Accounting Oversight Board (PCAOB). Detta innebär att publiceringen av företagets bokslutskommuniké för 2020 senareläggs till den 17 mars 2021.Saniona bedömer att omräkningarna, som har att göra med bokföringsmässiga justeringar, inte har väsentlig betydelse ur ett affärsmässigt perspektiv eftersom de inte påverkar företagets likviditet, prognos, verksamhetsplan eller genomförandet av kliniska studier.Som...

Continue reading

Kismet Acquisition Three Corp. Announces Closing of $287.5 Million Initial Public Offering

Moscow, Russia, Feb. 22, 2021 (GLOBE NEWSWIRE) — Kismet Acquisition Three Corp. (Nasdaq: KIIIU) (the “Company”) announced today that it closed its initial public offering of 28,750,000 units, which included the full exercise of the underwriters’ option to purchase additional units. The offering was priced at $10.00 per unit, generating total gross proceeds of $287,500,000.The units began trading on the Nasdaq Capital Market under the ticker symbol “KIIIU” on February 18, 2021. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants...

Continue reading

TILT Holdings, Inc. Announces Assignment of Ermont, Inc. Note Receivable

PHOENIX, Feb. 22, 2021 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced the assignment by its subsidiary, SH Finance Company, LLC, of the Loan and Security Agreement entered into with Ermont, Inc. (the “Ermont Note”) to Teneo Funds SPVi LLC, through an arm’s-length third-party transaction, in exchange for $1,250,000 in cash and a portion of future collections pursuant to the Ermont Note. The assignment agreement contains standard representations, warranties and indemnifications between the parties.“We believe that the assignment of the Ermont Note is a substantial step in helping to resolve certain concerns...

Continue reading

Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it has granted an inducement award to one new non-executive employee, Christy Stolzer, who joined the company as Associate Director, Drug Safety.The award was made on February 22, 2021 under Oncternal’s 2021 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Oncternal as an inducement to join the Company. The inducement award to the Ms. Stolzer consists of options to purchase 60,000 shares of Oncternal common stock. The options have a 10-year term and an exercise price equal to $7.20 per share, the fair market value of Oncternal’s common stock on the date of grant....

Continue reading

Kismet Acquisition Two Corp. Announces Closing of $230 Million Initial Public Offering

Moscow, Russia, Feb. 22, 2021 (GLOBE NEWSWIRE) — Kismet Acquisition Two Corp. (Nasdaq: KAIIU) (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, which included the full exercise of the underwriters’ option to purchase additional units. The offering was priced at $10.00 per unit, generating total gross proceeds of $230,000,000.The units began trading on the Nasdaq Capital Market under the ticker symbol “KAIIU” on February 18, 2021. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants...

Continue reading

Petrolympic Announces Completion of Debt Settlement

TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Petrolympic Ltd. (TSXV: PCQ) (the “Company“) reports that its board of directors has approved the settlement of $100,000 of debt through the issuance of common shares of the Company (the “Debt Settlement“). Pursuant to the Debt Settlement, the Company would issue an aggregate of 1,428,571 common shares of the Company (the “Shares“) at a deemed price of $0.07 per Share to a creditor of the Company, who is an officer of the Company (the “Creditor“).The issuance of the Shares to the Creditor is subject to the approval of the TSX Venture Exchange. All securities issued will be subject to a four month hold period which will expire on the date that is four months and one day from the date of issue.As the Creditor is an insider of the Company, the...

Continue reading

Eldorado Gold Announces Maiden Inferred Mineral Resource of 803,000 Ounces at 9.5 g/t Gold at the Ormaque Deposit in Quebec

VANCOUVER, British Columbia, Feb. 22, 2021 (GLOBE NEWSWIRE) — Eldorado Gold Corporation, (“Eldorado” or the “Company”) is pleased to announce a maiden resource estimate for the recently-discovered Ormaque deposit near its Lamaque operations (Figure 1) in Quebec. Inferred Mineral Resources total 2,620,000 tonnes at a grade of 9.53 grams per tonne gold, for 803,000 ounces of contained gold.“This early exploration success at Ormaque highlights the outstanding growth potential at Lamaque,” said George Burns, President and CEO. “The short time frame from initial discovery to maiden inferred resource is a testament to the drive of our team and the strong exploration potential within our land package in the Abitibi Greenstone Belt. The strike continuity, vein orientation and dimensions of the Ormaque deposit exhibit important similarities...

Continue reading

CORRECTION – Fortress Transportation and Infrastructure LLC Announces Jefferson Energy Companies’ Successful Completion of its Cross Channel Pipelines Project to the ExxonMobil Beaumont Refinery

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline on Monday, February 22nd, 2021 by Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI), please note that the third paragraph including a quote has been removed altogether. The corrected release follows:Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI) and Jefferson Energy Companies (“Jefferson Energy”) are pleased to announce the successful completion of its Cross Channel Pipelines project. This project consists of six pipelines connecting the Jefferson Energy terminal to the ExxonMobil (NYSE:XOM) Beaumont refinery and allows for ratable and efficient pipeline movements of both refined products and crude oil between the two locations. Barge traffic on the Neches River and at the Jefferson Energy terminal will...

Continue reading

Sports Ventures Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants

Bal Harbour, FL, Feb. 22, 2021 (GLOBE NEWSWIRE) — Sports Ventures Acquisition Corp. (the “Company”) announced today that, commencing February 26, 2021, holders of the 23,000,000 units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Stock Market LLC under the symbols “AKIC” and “AKICW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “AKICU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.